par
Gus Iversen, Editor in Chief | December 15, 2025
WellSpan Health is broadening its partnership with Aidoc to implement the company's AI platform, aiOS, across all of its hospitals and care locations.
The expansion builds on a relationship that began in 2022, during which the health system integrated Aidoc’s radiology tools to support diagnostic workflows and triage in emergency imaging.
The York, Pennsylvania-based health system will now activate 21 additional AI-powered care pathways across seven clinical specialties, including cardiology, neuroscience, and vascular surgery. The move brings Aidoc’s platform to nine hospitals and more than 250 care sites serving over one million patients annually.
Ad Statistics
Times Displayed: 17381
Times Visited: 47 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Roxanna Gapstur, president and CEO of WellSpan, said the expanded deployment is part of a broader effort to improve care quality and physician experience. “Aidoc has augmented our radiologists’ expertise for higher quality and safety, greater accuracy and a better work experience — especially important amid today’s physician shortage,” she said in a statement.
Over the past year, Aidoc’s platform reviewed more than 200,000 patient cases within the WellSpan system, flagging over 10,000 potentially critical findings, including pulmonary embolism, brain hemorrhage, and vascular occlusion. The company said the AI system has contributed to faster turnaround times and helped ease strain on radiology teams during a period of widespread staffing shortages.
With full integration into WellSpan’s Epic EMR and imaging systems, the AI platform will now support additional use cases, including detection of pneumothorax, aortic dissection, rib fractures, and free air in the abdomen or pelvis. Third-party tools for lung nodule and breast lesion detection will also be included.
Aidoc CEO Elad Walach called WellSpan’s approach “a bold, systemwide” deployment of AI. “They’ve taken a bold, systemwide approach that treats AI as core clinical infrastructure, not a point solution,” he said.
WellSpan and Aidoc also plan to collaborate on developing new AI tools as part of the expanded agreement.
